Product Code: TMRGL14723
The report provides revenue of the global pressure ulcers treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pressure ulcers treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pressure ulcers treatment market.
The report delves into the competitive landscape of the global pressure ulcers treatment market. Key players operating in the global pressure ulcers treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global pressure ulcers treatment market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pressure Ulcers Treatment Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Pressure Ulcers Treatment Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
- 4.5. Porter's Five Force Analysis
5. Market Outlook
- 5.1. Pricing Trends
- 5.2. Disease Prevalence & Incidence Rate globally with key countries
- 5.3. Pipeline Analysis
- 5.4. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
- 5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Pressure Ulcers Treatment Market Analysis and Forecast, by Treatment Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Treatment Type, 2017-2031
- 6.3.1. Wound Care Dressing
- 6.3.1.1. Antimicrobial Dressings
- 6.3.1.2. Foam Dressings
- 6.3.1.3. Hydrocolloid Dressings
- 6.3.1.4. Film Dressings
- 6.3.1.5. Alginate Dressings
- 6.3.1.6. Hydrogel Dressings
- 6.3.1.7. Other Dressings
- 6.3.2. Wound Care Devices
- 6.3.2.1. Negative Pressure Wound Therapy (NPWT
- 6.3.2.2. Ultrasound Therapy
- 6.3.2.3. Others (HBOT & electromagnetic)
- 6.3.3. Active Therapies
- 6.3.3.1. Skin Grafts & Substitutes
- 6.3.3.2. Growth Factors
- 6.3.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
- 6.3.4. Others
- 6.3.4.1. Pressure Relief Devices
- 6.3.4.2. Traditional Wound Care Products
- 6.3.4.3. Others
- 6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Pressure Ulcers Treatment Market Analysis and Forecast, by Type of Wound
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Type of Wound, 2017-2031
- 7.3.1. Stage 1
- 7.3.2. Stage 2
- 7.3.3. Stage 3
- 7.3.4. Stage 4
- 7.4. Market Attractiveness Analysis, by Type of Wound
8. Global Pressure Ulcers Treatment Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospital Inpatient Settings
- 8.3.2. Hospital Outpatient Settings
- 8.3.3. Community Health Centers
- 8.3.4. Home Health Care
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Pressure Ulcers Treatment Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast By Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Pressure Ulcers Treatment Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Treatment Type, 2017-2031
- 10.2.1. Wound Care Dressing
- 10.2.1.1. Antimicrobial Dressings
- 10.2.1.2. Foam Dressings
- 10.2.1.3. Hydrocolloid Dressings
- 10.2.1.4. Film Dressings
- 10.2.1.5. Alginate Dressings
- 10.2.1.6. Hydrogel Dressings
- 10.2.1.7. Other Dressings
- 10.2.2. Wound Care Devices
- 10.2.2.1. Negative Pressure Wound Therapy (NPWT
- 10.2.2.2. Ultrasound Therapy
- 10.2.2.3. Others (HBOT & electromagnetic)
- 10.2.3. Active Therapies
- 10.2.3.1. Skin Grafts & Substitutes
- 10.2.3.2. Growth Factors
- 10.2.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
- 10.2.4. Others
- 10.2.4.1. Pressure Relief Devices
- 10.2.4.2. Traditional Wound Care Products
- 10.2.4.3. Others
- 10.3. Market Value Forecast, by Type of Wound, 2017-2031
- 10.3.1. Stage 1
- 10.3.2. Stage 2
- 10.3.3. Stage 3
- 10.3.4. Stage 4
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospital Inpatient Settings
- 10.4.2. Hospital Outpatient Settings
- 10.4.3. Community Health Centers
- 10.4.4. Home Health Care
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Treatment Type
- 10.6.2. By Type of Wound
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Pressure Ulcers Treatment Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Treatment Type, 2017-2031
- 11.2.1. Wound Care Dressing
- 11.2.1.1. Antimicrobial Dressings
- 11.2.1.2. Foam Dressings
- 11.2.1.3. Hydrocolloid Dressings
- 11.2.1.4. Film Dressings
- 11.2.1.5. Alginate Dressings
- 11.2.1.6. Hydrogel Dressings
- 11.2.1.7. Other Dressings
- 11.2.2. Wound Care Devices
- 11.2.2.1. Negative Pressure Wound Therapy (NPWT
- 11.2.2.2. Ultrasound Therapy
- 11.2.2.3. Others (HBOT & electromagnetic)
- 11.2.3. Active Therapies
- 11.2.3.1. Skin Grafts & Substitutes
- 11.2.3.2. Growth Factors
- 11.2.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
- 11.2.4. Others
- 11.2.4.1. Pressure Relief Devices
- 11.2.4.2. Traditional Wound Care Products
- 11.2.4.3. Others
- 11.3. Market Value Forecast, by Type of Wound, 2017-2031
- 11.3.1. Stage 1
- 11.3.2. Stage 2
- 11.3.3. Stage 3
- 11.3.4. Stage 4
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospital Inpatient Settings
- 11.4.2. Hospital Outpatient Settings
- 11.4.3. Community Health Centers
- 11.4.4. Home Health Care
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Russia
- 11.5.7. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Treatment Type
- 11.6.2. By Type of Wound
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Pressure Ulcers Treatment Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Treatment Type, 2017-2031
- 12.2.1. Wound Care Dressing
- 12.2.1.1. Antimicrobial Dressings
- 12.2.1.2. Foam Dressings
- 12.2.1.3. Hydrocolloid Dressings
- 12.2.1.4. Film Dressings
- 12.2.1.5. Alginate Dressings
- 12.2.1.6. Hydrogel Dressings
- 12.2.1.7. Other Dressings
- 12.2.2. Wound Care Devices
- 12.2.2.1. Negative Pressure Wound Therapy (NPWT)
- 12.2.2.2. Ultrasound Therapy
- 12.2.2.3. Others (HBOT & electromagnetic)
- 12.2.3. Active Therapies
- 12.2.3.1. Skin Grafts & Substitutes
- 12.2.3.2. Growth Factors
- 12.2.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
- 12.2.4. Others
- 12.2.4.1. Pressure Relief Devices
- 12.2.4.2. Traditional Wound Care Products
- 12.2.4.3. Others
- 12.3. Market Value Forecast, by Type of Wound, 2017-2031
- 12.3.1. Stage 1
- 12.3.2. Stage 2
- 12.3.3. Stage 3
- 12.3.4. Stage 4
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospital Inpatient Settings
- 12.4.2. Hospital Outpatient Settings
- 12.4.3. Community Health Centers
- 12.4.4. Home Health Care
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Treatment Type
- 12.6.2. By Type of Wound
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Pressure Ulcers Treatment Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Treatment Type, 2017-2031
- 13.2.1. Wound Care Dressing
- 13.2.1.1. Antimicrobial Dressings
- 13.2.1.2. Foam Dressings
- 13.2.1.3. Hydrocolloid Dressings
- 13.2.1.4. Film Dressings
- 13.2.1.5. Alginate Dressings
- 13.2.1.6. Hydrogel Dressings
- 13.2.1.7. Other Dressings
- 13.2.2. Wound Care Devices
- 13.2.2.1. Negative Pressure Wound Therapy (NPWT)
- 13.2.2.2. Ultrasound Therapy
- 13.2.2.3. Others (HBOT & electromagnetic)
- 13.2.3. Active Therapies
- 13.2.3.1. Skin Grafts & Substitutes
- 13.2.3.2. Growth Factors
- 13.2.3.3. Others (hemostatic agents, sealants (collagen and fibrin sealants))
- 13.2.4. Others
- 13.2.4.1. Pressure Relief Devices
- 13.2.4.2. Traditional Wound Care Products
- 13.2.4.3. Others
- 13.3. Market Value Forecast, by Type of Wound, 2017-2031
- 13.3.1. Stage 1
- 13.3.2. Stage 2
- 13.3.3. Stage 3
- 13.3.4. Stage 4
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospital Inpatient Settings
- 13.4.2. Hospital Outpatient Settings
- 13.4.3. Community Health Centers
- 13.4.4. Home Health Care
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Treatment Type
- 13.6.2. By Type of Wound
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Competitive Landscape
- 14.1. Market Player - Competition Matrix (by tier and size of companies)
- 14.2. Market Share Analysis, by Company, 2021
- 14.3. Company Profiles
- 14.3.1. Smith & Nephew plc
- 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.1.2. Company Financials
- 14.3.1.3. Growth Strategies
- 14.3.1.4. SWOT Analysis
- 14.3.2. Integra LifeSciences
- 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.2.2. Company Financials
- 14.3.2.3. Growth Strategies
- 14.3.2.4. SWOT Analysis
- 14.3.3. Hill-Rom Holdings, Inc.
- 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.3.2. Company Financials
- 14.3.3.3. Growth Strategies
- 14.3.3.4. SWOT Analysis
- 14.3.4. Molnlycke Health Care AB
- 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.4.2. Company Financials
- 14.3.4.3. Growth Strategies
- 14.3.4.4. SWOT Analysis
- 14.3.5. Essity Aktiebolag
- 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.5.2. Company Financials
- 14.3.5.3. Growth Strategies
- 14.3.5.4. SWOT Analysis
- 14.3.6. Cardinal Health
- 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.6.2. Company Financials
- 14.3.6.3. Growth Strategies
- 14.3.6.4. SWOT Analysis
- 14.3.7. 3M
- 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.7.2. Company Financials
- 14.3.7.3. Growth Strategies
- 14.3.7.4. SWOT Analysis
- 14.3.8. B. Braun Melsungen AG
- 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.8.2. Company Financials
- 14.3.8.3. Growth Strategies
- 14.3.8.4. SWOT Analysis
- 14.3.9. Acelity L.P., Inc.
- 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.9.2. Company Financials
- 14.3.9.3. Growth Strategies
- 14.3.9.4. SWOT Analysis
- 14.3.10. Coloplast Group
- 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.10.2. Company Financials
- 14.3.10.3. Growth Strategies
- 14.3.10.4. SWOT Analysis
- 14.3.11. ConvaTec Group PLC
- 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.11.2. Company Financials
- 14.3.11.3. Growth Strategies
- 14.3.11.4. SWOT Analysis